SOSylvin Ouedraogo

Sylvin Ouedraogo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sylvin Ouedraogo has a total of 51 co-authors. Here are the top co-authors by number of shared publications:

  • Lazare Belemnaba

    Département Médecine et Pharmacopée Traditionnelles – Pharmacie (MEPHATRA-PH), Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouagadougou, Burkina Faso

    4 shared publications
  • Rasmané Semdé

    Centre de Formation, de Recherche et d’Expertises en sciences du médicament (CEA-CFOREM), Université Joseph KI-ZERBO, Ouagadougou, Burkina Faso

    4 shared publications
  • Salfo Ouedraogo

    Research and Development Laboratory for Phytomedicines and Drugs (LR-D/PM), Institute for Research in Health Sciences (IRSS/CNRST), Ouagadougou, Burkina Faso; Laboratory of Drug Development (LADME), Joseph Ki-Zerbo University, Ouagadougou, Burkina Faso

    4 shared publications
  • Mathieu Nitiema

    Département Médecine et Pharmacopée Traditionnelles – Pharmacie (MEPHATRA-PH), Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouagadougou, Burkina Faso

    3 shared publications
  • Souleymane Compaoré

    Département Médecine et Pharmacopée Traditionnelles – Pharmacie (MEPHATRA-PH), Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouagadougou, Burkina Faso

    3 shared publications
  • Tata Kadiatou Traore

    Research and Development Laboratory for Phytomedicines and Drugs (LR-D/PM), Institute for Research in Health Sciences (IRSS/CNRST), Ouagadougou, Burkina Faso

    3 shared publications

Latest Publications

  • Open Access

    Antihypertensive and Vascular Endothelium Protection Effect of the Ethyl Acetate Fraction of Phaseolus vulgaris Pods in L-NAME-induced Hypertensive Mice

    by Windingoudi Rimwagna Christian Ouedraogo, Mathieu Nitiema, Boukaré Kabore, Souleymane Compaore, Aristide Traore, Moussa Ouedraogo, Rasmané Semde, Fifamin Judith Ahounou Aïkpe, Felix Bondo Kini, Lazare Belemnaba, et al.

    Vascular endothelium, in addition to functioning as a physical barrier, plays a crucial role in regulating blood pressure. Endothelial protective mechanisms offer an alternative way to prevent cardiovascular risks, including hypertension. This study aimed to demonstrate the vasculoprotective and antihypertensive potential of the ethyl acetate fraction of Phaseolus vulgaris (EPV) pods in mice. Naval Medical Research Institute (NMRI) mice were randomized, and hypertension was induced by oral administration of LNAME (Lῳ- Nitro Arginine Methyl Ester). Subsequently, EPV and captopril were administered to the hypertensive mice. Physical parameters, blood pressure components, and biochemical conditions were measured. Vascular protection was assessed by measuring NO-dependent vasorelaxation of the aortic ring in the study mice. Phytochemical analysis of EPV was performed by high-performance liquid chromatography-mass spectrometry. Captopril and EPV significantly reduced blood pressure in LNAME-induced hypertensive mice, with the most effective doses of 5 mg/kg captopril and 20 mg/kg EPV. Furthermore, two-way ANOVA with Bonferroni post-tests showed that mice treated with EPV responded better in aortic rings, with strong vasorelaxation in the presence of ACh (acetylcholine) and SNP (sodium nitroprusside), compared with mice treated with LNAME alone. The weight variation and biochemical parameters in high-tension mice improved significantly with doses of captopril and EPV. Molecules are known to have beneficial effects on cardiovascular health, most of which are chlorogenic acid, quercetin glucoside, and p-coumaroylquinic acid. This investigation showed that the EPV had antihypertensive and cardiovascular effects in LNAME hypertensive mice, as well as a protective effect on the vascular endothelium.

  • Open Access

    Physicochemical and microbiological characteristics of Calotropis procera Ait. root bark powders from 20 sites in Burkina Faso for standardization

    by Salfo Ouedraogo, Tata Kadiatou Traore, Manegrebem Adele Ouedraogo, Souleymane Compaore, Axelle Astrid Lofo, Boukari Kabore, Rene Dofini Magnini, Mathieu Nitiema, Moumouni Koala, Lazare Belemnaba, et al.

    Calotropis procera is a component of the phytomedicine FACA®, used to manage sickle cell disease in Burkina Faso. This work aimed to standardize plant powders by evaluating the physicochemical characteristics and microbial quality of Calotropis procera root bark powders from different sites, with properties similar to those of the reference harvest site, to optimize the production of the phytomedicine. The samples were collected from different geographical areas of Burkina Faso during the dry season. The population, physicochemical characteristics, and microbial quality of each powder were evaluated. Twenty (20) geolocated harvest sites were identified with various soil types (clay, silt, gravel, and sand). The availability of Calotropis procera was high in Ziniaré, Ouaga 1, and Boromo; average across 8 sites; and low across 9. Physicochemical analyses of the powders revealed general uniformity in pH and residual moisture content. However, differences were observed in color, bitterness, and hygroscopicity. Total phenolics could serve as tracers, given their content is comparable to that of the reference. All samples complied with the specifications of the European Pharmacopeia 11th edition for total aerobic bacteria, yeasts and molds, and E. coli. Pathogens such as Salmonella and Staphylococcus aureus have been found in some powders. This study identified the optimal sites for collecting Calotropis procera samples. Keywords: Sickle cell disease; Calotropis procera; root bark; geographical variability.

  • Open Access

    Development of Lozenges from Fruit Extract of Balanites aegyptiaca (L) Delile (Zygophyllaceae) for the Treatment of Occasional Constipation

    by Ouedraogo Salfo, Traore Kadiatou, Boly Laurent, Tapsoba Carine, Millogo Olivia, Atchade Constantin, Kabore Donacienne, Traore Safiatou, Goumbri Florent, Traore Aristide, et al.

    Balanites aegyptiaca (L.) Del. is a plant whose fruit pulp is traditionally used to treat constipation. They possess inherent laxative properties. This study aimed to improve upon the traditional method of use by developing lozenges with these laxative properties. An infusion was performed, and the physicochemical characteristics of the lyophilized extract were determined. The lozenges were formulated from the extract, and their quality and laxative efficacy in vivo were controlled in NMRI strain mice. The extract was yellow, had a bitter-sweet taste, a characteristic smell, and a fine texture. The pH was 5.56, and the RMC was 1.16%. The powder was highly hygroscopic, and the extraction yield was 33.71%, with a saponoside content of 2.76 μgED/mg. Fifteen (15) formulations were prepared, and formulation F7 was selected for the incorporation of the extract. The F7 was yellow, sweet, with an uncharacteristic odor and a hard appearance. The lozenges were uniform (1.95±0.04 g), with an average pH of 5.85±0.07 and a saponoside content of 2.01±0.26 μgED/mg. The lozenges had an accelerated intestinal transit percentage of 75.74±3.22%, comparable to that of the extract (78.10±4.32%) and castor oil (81.84±9.46%). After slowing down transit with loperamide (45.24±2.38%), the lozenges (60.84±7.13%) brought the percentage close to normal transit (65.94±3.33%). This study highlighted the laxative efficacy of lozenges made from Balanites aegyptiaca fruit pulp extract.

  • Open Access

    Evaluation of organic acids, cytotoxicity, oral acute toxicity and diuretic effect of Phaseolus vulgaris crops ethyl acetate extract for cardiovascular health improvement

    by Windingoudi Rimwagna Christian Ouedraogo, Mathieu Nitiema, Boukaré Kabore, Souleymane Compaore, Moumouni Koala, Floricuta Ranga, Ramona Suharoschi, Fifamin Judith Ahounou Aïkpe, Felix Bondo Kini, Lazare Belemnaba, et al.

    Diuretics play an important role in managing high blood pressure. The aim of this study was to determine the organic acids, toxicity, and diuretic properties of the ethyl acetate fraction of Phaseolus vulgaris (EPV) in Wistar rats. High Performance Liquid Chromatography (HPLC) analysis has been used to detect and quantify the organic acids in the EPV fraction. Cytotoxicity tests of Artemia salina larvae and acute oral toxicity tests are carried out to determine the lethal concentrations and doses of EPV. The diuretic properties of EPV were evaluated in Wistar rats for 24 hours by measuring diuresis parameters and urinary electrolyte concentrations. Results: The HPLC analysis report showed the presence of various organic acids in EPV, including malic acid (117.79±0.01 mg/g), oxalic acid (52.47±0.00 mg/g), and citric acid (42.85±0.00 mg/g). EPV seems almost non-toxic, as demonstrated by the larvicidal death lethal concentration (LC50) and the estimated 50% lethal dose of 5000 mg/kg body weight. Measuring diuresis parameters reports that EPV may increase urine volume at the test doses. In addition, the report states that EPV affects electrolyte balance by increasing the excretion of Na+, K+, Cl+, and pH. The intensity of the diuretic effect was significantly higher than that of the negative control. These effects are less pronounced than those caused by pharmacological references but are largely similar to those caused by furosemide. A high concentration of oxalic acids, citric acids and ascorbic acids, combined with the proven urine effects of EPV, strengthens the antihypertension, antioxidant and vasorelaxant properties previously reported. These drug properties demonstrate not only the traditional use of EPV but also its use as a database for the development of innovative therapeutic tools to reduce the risk of cardiovascular diseases. Keywords: Diuretic effect; Organic acids; Phaseolus vulgaris ethyl acetate fraction

  • Open Access

    Formulation of Effervescent Granules Based on Calotropis procera Ait Powder (Apocynaceae) and Zanthoxylum zanthoxyloides Lam (Rutaceae)

    by Ouédraogo Salfo, Atchadé Constantin, Traoré Kadiatou, Rouamba Martin, Traoré Safiatou, Goumbri Florent, Yaméogo Josias, Ouédraogo Sylvin, Semdé Rasmané

    Introduction: Sickle cell disease is a genetic disease that affects nearly 5% of the world's population and is particularly prevalent in sub-Saharan Africa. The inaccessibility of modern treatment has led to the development of a phytomedicine called FACA® in Burkina Faso. It is formulated in capsule form and contains a mixture of powdered root barks of Zanthoxylum zanthoxyloides and Calotropis procera . This study aims to propose an alternative, easier-to-administer form for patients who have difficulty swallowing capsules by developing effervescent granules. Materials and methods: Pre-formulation studies focused on analyzing the physicochemical and pharmaco-technical properties of the powder mixture. These included macroscopic and organoleptic aspects, pH, residual moisture content, hygroscopicity, granulometry, and flow. Effervescent granules were formulated and manufactured by the wet granulation method. Five formulations (F1-F5) were produced. Citric acid and sodium bicarbonate were used as effervescent vehicles at a ratio of 1:1.25. PVP was used as a binding agent, sucrose as a sweetener, and cornstarch as a diluent. The granulation liquid was distilled water. The granules produced were evaluated for their physicochemical properties and disintegration time. Results and discussion: the results of the physicochemical and pharmaco-technical characteristics guided the choice of excipients and the manufacturing process. The formulations were beige in color and granular in appearance. THR values were <10%, pH ranged from 5.20 ± 0.29 to 5.91 ± 0.17. They were more or less hygroscopic and presented good rheological properties with an effervescence time satisfying the specifications of the European Pharmacopoeia 11th edition. Conclusion: F4 formulation had the best characteristics and could serve as an alternative to capsules. Indeed, being dispersed in water before administration, these granules could be well tolerated by the gastrointestinal tract and promote a more rapid action of the drug at a time of crisis.

  • Open Access

    Toxicity assessment of a phytomedicine based on an almond extract from the fruit of Balanites aegyptiaca (L.) DELILE (Zygophyllaceae) intended for helminthiases care in Burkina Faso

    by Geoffroy Gueswindé Ouedraogo, Bonewendé Mohamed Belemlilga, Tombègou Kouguilima, Gaëtan Donzéo Somda, Sylvain Ilboudo, Salfo Ouedraogo, Aristide Traore, Lazare Belemnaba, Félix Bondo Kini, Sylvin Ouedraogo

    Balanites aegyptiaca (L.) Delile (Zygophyllaceae) is a medicinal plant used in traditional medicine in Burkina Faso to treat helminthiasis. Using an ethnopharmacological approach, the "Institut de Recherche en Sciences de la Santé (IRSS)" has developed a phytomedicine based on an almond extract from the fruit of this plant for the treatment of helminthiasis. This study aimed to assess the acute and subacute oral toxicity and in vivo mutagenicity of phytomedicine. The acute toxicity study was carried out following OECD guideline 423 by administering a single dose of 2000 mg/kg body weight (bw) of phytomedicine orally to female mice. For subacute toxicity, OECD guideline 407 was used. Four batches of 10 rats (5 males and 5 females) were used, including a control batch and three treated batches receiving a daily oral administration of the phytomedicine at doses of 250, 500, or 1000 mg/kg bw for 28 days. The mutagenicity test was performed according to OECD guideline 474; five batches of 10 mice (5 males and 5 females) were given oral doses of 500, 1000 or 2000 mg/kg bw of phytomedicine, colchicine as a positive control at 5mg/kg bw and distilled water as a negative control. In the acute toxicity test, the LD50 was estimated at 5000 mg/kg bw. The subacute toxicity study showed no mortality or signs of toxicity in rats. Biochemical analysis revealed no significant differences between control rats and those treated with the phytomedicine for glucose, creatinine, total cholesterol, triglycerides, AST, chlorine, calcium, and potassium. On the other hand, serum levels of ALT, total protein, PO43-, and Na+ were significantly reduced in some treated rats. The mutagenicity test showed no change in micronucleus frequency between treated and control mice. This study showed that phytomedicine based on an extract of B. aegyptiaca fines would present less danger to users. Keywords: Balanites aegyptiaca, acute toxicity, subacute toxicity, micronucleated erythrocytes, phytomedicine.

  • Open Access

    Impacts of SAYE PLUS , an Antimalarial Phytomedicine With Potential Anti‐COVID‐19, on the Physical, Biological, and Genotoxicity Parameters of Rodents in Short‐Term Toxicity Studies

    by Joël Ouédraogo, Sylvain Ilboudo, Geoffroy Gueswindé Ouédraogo, Virginie Dakuyo, Salfo Ouédraogo, Gaétan D. Somda, Jean Claude Romaric Pingdwindé Ouédraogo, Moussa Ouédraogo, Rasmané Semdé, Sylvin Ouédraogo

    In response to the COVID‐19 pandemic and following the World Health Organization’s call for action, several traditional medicine recipes were used without any scientific prerequisites concerning their safety. The current study investigated several short‐term toxicity parameters of SAYE PLUS, an antimalarial phytomedicine used in COVID‐19 patients in Burkina Faso. Following the guidelines of the Organisation for Economic Co‐operation and Development (OECD), the safety profile of SAYE PLUS was investigated in a battery of tests in rats and mice. In an acute toxicity study, male and female rats received a single oral dose of 2000 mg/kg b.w. of the test substance. For the subacute toxicity test, male and female rats received daily oral doses of 250, 500, and 1000 mg/kg b.w. for 28 days. Acute and subacute toxicity tests were accompanied by food and water intake, body and organ relative weight, and blood chemistry of animals recording. In mutagenicity, sperm quality, and lipid peroxidation tests, mice were orally exposed to daily oral doses of 500, 1000, and 2000 mg/kg for seven days. Single dose of 2000 mg/kg b.w. of SAYE PLUS did not cause rats mortality. The LD 50 is more than 2000 mg/kg b.w. Daily administration of SAYE PLUS for 28 days did not induce any significant change in the water or food intake and the body or organ relative weights of animals. Furthermore, no significant change was observed in biochemical parameters. In the test conditions, the recipe did not induce an increase of micronucleus or changes in sperm motility and number. However, all tested doses of SAYE PLUS induced a significant increase in MDA levels in mice serum. These results show that SAYE PLUS did not induce negative impacts on studied parameters, but the possible lipidic peroxidation observed must be further investigated for its mechanism and effects.


  • Open Access

    Anthropometric characteristics between ever and never screened for hypertension in Burkina Faso

    by Jeoffray Diendéré, Toussaint Rouamba, Jean Kaboré, Augustin N. Zeba, Halidou Tinto, Sylvin Ouédraogo, Athanase Millogo, Séni Kouanda

    Background: Excess body weight was associated with a higher chance for hypertension detection.Aim: To compare the anthropometric characteristics and blood pressure levels between Burkinabè adults who had ever been screened for hypertension and those who had never been screened, and to assess the associated factors with the uptake of hypertension screening.Setting: Urban and rural Burkina Faso.Methods: This was a secondary analysis using the Burkina Faso 2013 WHO Stepwise approach to Surveillance cross-sectional survey. Data from 3831 adult men and women were analysed. Descriptive and analytical analyses were performed using Student’s t, ANOVA, χ2, Fisher’s exact tests and logistic regression.Results: Among participants, 41.6% (95% CI: 40.0–43.1) had never been screened for hypertension, and compared to those who had ever been screened, they had significantly lower mean weight, waist circumference and body mass index, and lower prevalence of overweight or obesity and abdominal obesity. The prevalence of prehypertension was similar between the two groups (around 40%) and the prevalence of hypertension was lower in those who had never been screened (17.3% vs 20.8%; p = 0.007). Overweight or obesity (adjusted odds ratio [aOR] = 1.3; p = 0.03) and abdominal obesity (aOR = 1.3; p = 0.002) were associated with screening uptake.Conclusion: The Burkinabè adults who had never been screened for hypertension were apparently thin, but pre-hypertension or hypertension was also common among them. Increasing body size (excess weight or abdominal obesity) may be the reason for screening uptake.Contribution: Specific awareness-raising messages to motivate slim people to undergo screening need to be developed.